BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38828367)

  • 21. A novel prognostic model based on four circulating miRNA in diffuse large B-cell lymphoma: implications for the roles of MDSC and Th17 cells in lymphoma progression.
    Sun R; Zheng Z; Wang L; Cheng S; Shi Q; Qu B; Fu D; Leboeuf C; Zhao Y; Ye J; Janin A; Zhao WL
    Mol Oncol; 2021 Jan; 15(1):246-261. PubMed ID: 33107145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA Expression Profile in Bone Marrow and Lymph Nodes in B-Cell Lymphomas.
    Veryaskina YA; Titov SE; Kovynev IB; Pospelova TI; Fyodorova SS; Shebunyaeva YY; Sumenkova DV; Zhimulev IF
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: a systematic review.
    Lopez-Santillan M; Larrabeiti-Etxebarria A; Arzuaga-Mendez J; Lopez-Lopez E; Garcia-Orad A
    Oncotarget; 2018 Apr; 9(32):22850-22861. PubMed ID: 29854319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma.
    Lenze D; Leoncini L; Hummel M; Volinia S; Liu CG; Amato T; De Falco G; Githanga J; Horn H; Nyagol J; Ott G; Palatini J; Pfreundschuh M; Rogena E; Rosenwald A; Siebert R; Croce CM; Stein H
    Leukemia; 2011 Dec; 25(12):1869-1876. PubMed ID: 21701491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of miRNAs as biomarkers for predicting the outcomes of diffuse large B-cell lymphoma patients.
    Hu M; Wang X; Liu N; Ding K; Zhang G; Liu X
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34109978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs associated to single drug components of R-CHOP identifies diffuse large B-cell lymphoma patients with poor outcome and adds prognostic value to the international prognostic index.
    Due H; Brøndum RF; Young KH; Bøgsted M; Dybkær K
    BMC Cancer; 2020 Mar; 20(1):237. PubMed ID: 32192453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The Importance of MicroRNA Deregulation in the Molecular Pathogenesis and Histological Transformation of Follicular Lymphoma].
    Musilová K; Deván J; Zlámalíková L; Křen L; Móciková H; Procházka V; Mayer J; Trněný M; Janíková A; Mráz M
    Klin Onkol; 2017; 30(Supplementum1):163-165. PubMed ID: 28471196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs as novel biomarkers in diffuse large B-cell lymphoma--a systematic review.
    Jørgensen LK; Poulsen MØ; Laursen MB; Marques SC; Johnsen HE; Bøgsted M; Dybkær K
    Dan Med J; 2015 May; 62(5):. PubMed ID: 26050834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures.
    Mahadevan D; Spier C; Della Croce K; Miller S; George B; Riley C; Warner S; Grogan TM; Miller TP
    Mol Cancer Ther; 2005 Dec; 4(12):1867-79. PubMed ID: 16373702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocyte-derived canine familiaris-microRNAs as serum biomarkers of hepatic steatosis or fibrosis as implicated in the pathogenesis of canine cholecystolithiasis.
    El-Sebaey AM; Abramov PN
    Vet Clin Pathol; 2022 Feb; 50 Suppl 1():37-46. PubMed ID: 34031917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Next-generation sequencing of miRNAs in clinical samples of Epstein-Barr virus-associated B-cell lymphomas.
    Sakamoto K; Sekizuka T; Uehara T; Hishima T; Mine S; Fukumoto H; Sato Y; Hasegawa H; Kuroda M; Katano H
    Cancer Med; 2017 Mar; 6(3):605-618. PubMed ID: 28181423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and comparison of microRNA expression in the serum of Doberman Pinschers with dilated cardiomyopathy and healthy controls.
    Steudemann C; Bauersachs S; Weber K; Wess G
    BMC Vet Res; 2013 Jan; 9():12. PubMed ID: 23327631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma.
    Larrabeiti-Etxebarria A; Bilbao-Aldaiturriaga N; Arzuaga-Mendez J; Martin-Arruti M; Cozzuto L; Gaafar A; Ruiz-Diaz I; Guerra I; Martin-Guerrero I; Lopez-Lopez E; Gutierrez-Camino A
    Sci Rep; 2023 Jul; 13(1):12159. PubMed ID: 37500691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression profiling of microRNA and their target genes in peripheral T cell lymphoma, not otherwise specified].
    Li M; Lü N; Liu HX; Chen DB; Zhang JZ
    Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):519-24. PubMed ID: 24246916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma.
    Marques SC; Ranjbar B; Laursen MB; Falgreen S; Bilgrau AE; Bødker JS; Jørgensen LK; Primo MN; Schmitz A; Ettrup MS; Johnsen HE; Bøgsted M; Mikkelsen JG; Dybkær K
    Exp Hematol; 2016 Apr; 44(4):238-46.e2. PubMed ID: 26854484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients.
    Song G; Gu L; Li J; Tang Z; Liu H; Chen B; Sun X; He B; Pan Y; Wang S; Cho WC
    Ann Hematol; 2014 Oct; 93(10):1735-43. PubMed ID: 24858372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selecting optimum miRNA panel for miRNA signature-based companion diagnostic model to predict the response of R-CHOP treatment in diffuse large B-cell lymphoma.
    Nakamura N; Hamada R; Kaneko H; Ohta S
    J Biosci Bioeng; 2023 Apr; 135(4):341-347. PubMed ID: 36732209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MUM-1 in canine lymphoma: A pilot study.
    Riccardi E; Klopfleish R; Bell F; Calvez SL; Dawson LJ
    Vet Pathol; 2023 May; 60(3):316-319. PubMed ID: 36800915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
    Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
    Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas.
    Fischer L; Hummel M; Korfel A; Lenze D; Joehrens K; Thiel E
    Neuro Oncol; 2011 Oct; 13(10):1090-8. PubMed ID: 21803762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.